Answers are grounded in this paper and cite their sources.
The clinical efficacy of antibiotics has progressively declined over the past decades as a consequence of the global spread of antimicrobial resistance, a phenomenon that is particularly pronounced among the so-called ESKAPEE pathogens: Enterococcus species, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, Enterobacter species, and Escherichia coli. Collectively, these bacteria are responsible for more than 50% of infection-related deaths worldwide, and multidrug-resistance is highly prevalent among them. This alarming trend poses a critical threat to global public health and underscores the urgent need for innovative therapeutic strategies. One such approach involves the use of polymers as drug delivery systems for both conventional antibiotics and novel antimicrobial compounds, in the form of nanoparticles or polymer prodrugs, to circumvent resistance mechanisms. Other promising strategies are polycations with intrinsic antibacterial activity that act through mechanisms not yet widely exploited and polymers exerting photodynamic and photothermal effects. In this review, we summarize and discuss the current evidence for the efficacy of polymer-based strategies against drug-resistant ESKAPEE infections.
No takes yet. Share an insight, caveat, or question.
Tô et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: